The American Journal of Medicine
Volume 122, Issue 4, Supplement 2 , Pages S1-S6 , April 2009

Introduction

  • Elizabeth A. Bower, MD, MPH

      Affiliations

    • Corresponding Author InformationRequests for reprints should be addressed to Elizabeth A. Bower, MD, MPH, Department of Medicine, Division of General Internal Medicine, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, L-602, Portland, Oregon 97239-3098
    • ,
  • Donald E. Girard, MD

References 

  1. Rosamond W, Flegal K, Furie K, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics—2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008;117:e25–e146
  2. Hillen T, Coshall C, Tilling K, Rudd AG, McGovern R, Wolfe CD South London Stroke Register. Cause of stroke recurrence is multifactorial: patterns, risk factors, and outcomes of stroke recurrence in the South London Stroke Register. Stroke. 2003;34:1457–1463
  3. Hankey GJ. Long-term outcome after ischaemic stroke/transient ischaemic attack. Cerebrovasc Dis. 2003;16(suppl 1):14–19
  4. Kaplan RC, Tirschwell DL, Longstreth WT, et al. Heart Protection Study Collaborative Group Vascular events, mortality, and preventive therapy following ischemic stroke in the elderly. Neurology. 2005;65:835–842
  5. Cuffe M. Preventing vascular events in high-risk patients: primary care on the front line. Clin Cardiol. 2006;29(suppl):II2–II3
  6. Goldstein LB, Adams R, Alberts MJ, et al. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council. Stroke. 2006;37:1583–1633
  7. Davis BR, Vogt T, Frost PH, et al. Systolic Hypertension in the Elderly Program Cooperative Research Group Risk factors for stroke and type of stroke in persons with isolated systolic hypertension. Stroke. 1998;29:1333–1340
  8. Eastern Stroke and Coronary Heart Disease Collaborative Research Group. Blood pressure, cholesterol, and stroke in eastern Asia. Lancet. 1998;352:1801–1807
  9. Adler AI, Stratton IM, Neil HA, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ. 2000;321:412–419
  10. Chobanian AV, Bakris GL, Black HR, et al. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure National High Blood Pressure Education Program Coordinating Committee The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560–2572
  11. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997;157:2413–2446
  12. Prospective Studies Collaboration. Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Lancet. 1995;346:1647–1653
  13. Zhang X, Patel A, Horibe H, et al. Cholesterol, coronary heart disease, and stroke in the Asia Pacific region. Int J Epidemiol. 2003;32:563–572
  14. Collins R, Armitage J, Parish S, Sleight P, Peto R Heart Protection Study Collaborative Group. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet. 2004;363:757–767
  15. Amarenco P, Bogousslavsky J, Callahan A, et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006;355:549–559
  16. Horenstein RB, Smith DE, Mosca L. Cholesterol predicts stroke mortality in the Women's Pooling Project. Stroke. 2002;33:1863–1868
  17. Amarenco P, Labreuche J, Lavallée P, Touboul PJ. Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis. Stroke. 2004;35:2902–2909
  18. Grundy SM, Cleeman JI, Merz CN, et al. National Heart, Lung, and Blood Institute, the American College of Cardiology Foundation, and the American Heart Association Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110:227–239
  19. Jeerakathil T, Johnson JA, Simpson SH, Majumdar SR. Short-term risk for stroke is doubled in persons with newly treated type 2 diabetes compared with persons without diabetes: a population-based cohort study. Stroke. 2007;38:1739–1743
  20. Janghorbani M, Hu FB, Willett WC, et al. Prospective study of type 1 and type 2 diabetes and risk of stroke subtypes: the Nurses' Health Study. Diabetes Care. 2007;30:1730–1735
  21. Nathan DM, Cleary PA, Backlund JY, et al. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353:2643–2653
  22. Advance Collaborative GroupPatel A, MacMahon S, Chalmers J, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358:2560–2572
  23. Action to Control Cardiovascular Risk in Diabetes Study GroupGerstein HC, Miller ME, Byington RP, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2545–2559
  24. Wolf PA, D'Agostino RB, Kannel WB, Bonita R, Belanger AJ. Cigarette smoking as a risk factor for stroke: the Framingham Study. JAMA. 1988;259:1025–1029
  25. Freund KM, Belanger AJ, D'Agostino RB, Kannel WB. The health risks of smoking (The Framingham Study: 34 years of follow-up). Ann Epidemiol. 1993;3:417–424
  26. Djousse L, Ellison RC, Beiser A, Scaramucci A, D'Agostino RB, Wolf PA. Alcohol consumption and risk of ischemic stroke: the Framingham Study. Stroke. 2002;33:907–912
  27. Mukamal KJ, Ascherio A, Mittleman MA, et al. Alcohol and risk for ischemic stroke in men: the role of drinking patterns and usual beverage. Ann Intern Med. 2005;142:11–19
  28. Gillum RF, Mussolino ME, Ingram DD. Physical activity and stroke incidence in women and men (The NHANES I Epidemiologic Follow-up Study). Am J Epidemiol. 1996;143:860–869
  29. Hu FB, Stampfer MJ, Colditz GA, et al. Physical activity and risk of stroke in women. JAMA. 2000;283:2961–2967
  30. Liu S, Manson JE, Lee IM, et al. Fruit and vegetable intake and risk of cardiovascular disease: the Women's Health Study. Am J Clin Nutr. 2000;72:922–928
  31. Liu S, Manson JE, Stampfer MJ, et al. Whole grain consumption and risk of ischemic stroke in women: a prospective study. JAMA. 2000;284:1534–1540
  32. FOOD Trial Collaboration. Poor nutritional status on admission predicts poor outcomes after stroke: observational data from the FOOD trial. Stroke. 2003;34:1450–1456
  33. Mink PJ, Scrafford CG, Barraj LM, et al. Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. Am J Clin Nutr. 2007;85:895–909
  34. Kurth T, Gaziano JM, Berger K, et al. Body mass index and the risk of stroke in men. Arch Intern Med. 2002;162:2557–2562
  35. Lee CD, Folsom AR, Blair SN. Physical activity and stroke risk: a meta-analysis. Stroke. 2003;34:2475–2481
  36. Bartolucci AA, Howard G. Meta-analysis of data from the six primary prevention trials of cardiovascular events using aspirin. Am J Cardiol. 2006;98:746–750
  37. Ridker PM, Cook NR, Lee IM, et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med. 2005;352:1293–1304
  38. Brigham and Women's Hospital, Bayer Clinical Trials. A study to assess the efficacy and safety of 100 mg acetylsalicylic acid in patients at moderate risk of cardiovascular disease (ARRIVE). http://clinicaltrials.gov/ct2/show/NCT00501059Accessed March 5, 2009
  39. Japanese Ministry of Health, Labour and Welfare, Japan Heart Foundation, Bayer HealthCare. Japanese Primary Prevention Project With Aspirin. http://clinicaltrials.gov/show/NCT00225849Accessed July 7, 2008. ClinicalTrials.gov Identifier NCT00225849
  40. Sacco RL, Adams R, Albers G, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: cosponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline. Circulation. 2006;113:e409–e449
  41. Coull AJ, Lovett JK, Rothwell PM Oxford Vascular Study. Population based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services. BMJ. 2004;328:326
  42. Elkind MSV. Outcomes after stroke: risk of recurrent ischemic stroke and other events. Am J Med. 2009;122(Suppl):S7–S13
  43. Ovbiagele B, Saver JL, Fredieu A, et al. In-hospital initiation of secondary stroke prevention therapies yields high rates of adherence at follow-up. Stroke. 2004;35:2879–2883
  44. Ovbiagele B, Saver JL, Fredieu A, et al. PROTECT: a coordinated stroke treatment program to prevent recurrent thromboembolic events. Neurology. 2004;63:1217–1222
  45. Wright J, Bibby J, Eastham J, et al. Multifaceted implementation of stroke prevention guidelines in primary care: cluster-randomised evaluation of clinical and cost effectiveness. Qual Saf Health Care. 2007;16:51–59
  46. Schwamm LH, Pancioli A, Acker JE, et al. Recommendations for the establishment of stroke systems of care: recommendations from the American Stroke Association's Task Force on the Development of Stroke Systems. Circulation. 2005;111:1078–1091
  47. Miller WR, Rollnick S. Motivational Interviewing: Preparing People for Change. 2nd ed.. New York: Guilford Press; 2002;
  48. Rubak S, Sandbaek A, Lauritzen T, Christensen B. Motivational interviewing: a systematic review and meta-analysis. Br J Gen Pract. 2005;55:305–312
  49. Prochaska JO, Norcross JC, DiClemente CC. Changing for Good. New York: Avon Books; 1995;

 Statement of author disclosure: Please see the Author Disclosures section at the end of this article.

PII: S0002-9343(09)00138-7

doi: 10.1016/j.amjmed.2009.02.004

The American Journal of Medicine
Volume 122, Issue 4, Supplement 2 , Pages S1-S6 , April 2009

Article Tools